Ofer Gonen, MediWound CEO
August 16, 2023 06:51 AM EDT
Pharma

Medi­Wound’s US launch of its top­i­cal gel for burns de­layed to Q1 due to man­u­fac­tur­ing ‘de­vi­a­tion’

Anna Brown

News Reporter

Medi­Wound has de­layed the US launch of its top­i­cal gel for burns to ear­ly next year due to a man­u­fac­tur­ing “de­vi­a­tion.” The com­pa­ny ini­tial­ly planned …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times